Practical considerations to implement the shorter regimen to MDR-TB patients in China

被引：3
作者：
Liu, Q. [1 ]
Sun, F. [1 ]
Li, Y. [1 ]
Bao, J. [2 ]
Zhang, Y. [1 ,3 ]
Zhang, W. [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, 12 WulumuqiZhong Rd, Shanghai 200040, Peoples R China
[2] NIAID, TB Clin Res Branch, Div AIDS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 10期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; BENEFIT; EUROPE;
D O I：
10.1016/j.cmi.2018.04.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1035 / 1036
页数：2
相关论文
共 50 条
[41]   Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients [J].
Park, Seung-Kyu ;
Hong, Sunghee ;
Eum, Seok-Yong ;
Lee, In Hee ;
Shin, Donk Ok ;
Cho, Jang Eun ;
Cho, Sungae ;
Cho, Sang-Nae .
TUBERCULOSIS, 2011, 91 (04) :300-307
[42]   Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India [J].
Kumar, P. ;
Kumar, P. ;
Balooni, V. ;
Singh, S. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (04) :434-439
[43]   9-12 months short treatment for patients with MDR-TB increases treatment success in Kyrgyzstan [J].
Zhdanova, Elena ;
Goncharova, Olga ;
Davtyan, Hayk ;
Alaverdyan, Sevak ;
Sargsyan, Aelita ;
Harries, Anthony D. ;
Maykanaev, Bolot .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (09) :66S-74S
[44]   Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study [J].
Bonnet, M. ;
Bastard, M. ;
du Cros, P. ;
Khamraev, A. ;
Kimenye, K. ;
Khurkhumal, S. ;
Hayrapetyan, A. ;
Themba, D. ;
Telnov, A. ;
Sanchez-Padilla, E. ;
Hewison, C. ;
Varaine, F. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (02) :177-186
[45]   Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China [J].
Gu, Pengcheng ;
Lu, Peng ;
Ding, Hui ;
Liu, Qiao ;
Ding, Xiaoyan ;
Chen, Yongfa ;
Zhu, Limei .
ANNALS OF MEDICINE, 2024, 56 (01)
[46]   Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naive MDR-TB Patients [J].
Van der Walt, Martha ;
Lancaster, Johanna ;
Odendaal, Ronel ;
Davis, Jeanne Garcia ;
Shean, Karen ;
Farley, Jason .
PLOS ONE, 2013, 8 (04)
[47]   Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths [J].
Wai, Pyae Phyo ;
Shewade, Hemant Deepak ;
Nang Thu Thu Kyaw ;
Kyaw, Khine Wut Yee ;
Thein, Saw ;
Thu, Aung Si ;
Oo, Myo Minn ;
Htwe, Pyae Sone ;
Tun, Moe Myint Theingi ;
Maung, Htet Myet Win ;
Soe, Kyaw Thu ;
Aung, Si Thu .
PLOS ONE, 2017, 12 (12)
[48]   Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand [J].
Suthum, Krairerk ;
Samosornsuk, Worada ;
Samosornsuk, Seksun .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (03) :268-276
[49]   Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria [J].
Oshi, Daniel ;
Chukwu, Joseph ;
Nwafor, Charles ;
Chukwu, Ngozi E. ;
Meka, Anthony O. ;
Anyim, Moses ;
Ukwaja, Kingsley N. ;
Alobu, Isaac ;
Ekeke, Ngozi ;
Oshi, Sarah N. .
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2020, 35 (04) :832-842
[50]   Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study [J].
Lin, Kunhe ;
Xiang, Li .
RISK MANAGEMENT AND HEALTHCARE POLICY, 2024, 17 :727-737
12345